nst-1024
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 27, 2020 (NCT04630366)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05889156 | Phase 2 | Jun 30, 2023 | NorthSea Therapeutics B.V. |
| NCT05368831 | Phase 1 | Jul 19, 2022 | NorthSea Therapeutics B.V. |
| NCT04630366 | Phase 1 | Oct 27, 2020 | NorthSea Therapeutics B.V. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NorthSea Therapeutics B.V. | For profit | 3 | 3 | 2 | 2020 |
1 organizations
Page 1 / 1